Literature DB >> 33966938

When to Discuss Prostate Cancer Screening With Average-Risk Men.

Roman Gulati1, Sigrid V Carlsson2, Ruth Etzioni3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33966938      PMCID： PMC8319088          DOI： 10.1016/j.amepre.2021.02.024

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN： 0749-3797            Impact factor:   6.604


× No keyword cloud information.
  34 in total

1.  Reconsidering the Trade-offs of Prostate Cancer Screening.

Authors:  Jonathan E Shoag; Yaw A Nyame; Roman Gulati; Ruth Etzioni; Jim C Hu
Journal:  N Engl J Med       Date:  2020-06-18       Impact factor: 91.245

2.  Overdiagnosis and Lives Saved by Reflex Testing Men With Intermediate Prostate-Specific Antigen Levels.

Authors:  Roman Gulati; Todd M Morgan; Teresa A'mar; Sarah P Psutka; Jeffrey J Tosoian; Ruth Etzioni
Journal:  J Natl Cancer Inst       Date:  2020-04-01       Impact factor: 13.506

3.  Personalized Risks of Over Diagnosis for Screen Detected Prostate Cancer Incorporating Patient Comorbidities: Estimation and Communication.

Authors:  Roman Gulati; Sarah P Psutka; Ruth Etzioni
Journal:  J Urol       Date:  2019-10-09       Impact factor: 7.450

4.  A Matched Cohort Analysis of Prostate Cancer Screening in Younger Men in Sweden.

Authors:  Roman Gulati; Ruth Etzioni
Journal:  Eur Urol       Date:  2016-04-16       Impact factor: 20.096

5.  Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  David C Grossman; Susan J Curry; Douglas K Owens; Kirsten Bibbins-Domingo; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; Mark Ebell; John W Epling; Alex R Kemper; Alex H Krist; Martha Kubik; C Seth Landefeld; Carol M Mangione; Michael Silverstein; Melissa A Simon; Albert L Siu; Chien-Wen Tseng
Journal:  JAMA       Date:  2018-05-08       Impact factor: 56.272

6.  Quality-of-life effects of prostate-specific antigen screening.

Authors:  Eveline A M Heijnsdijk; Elisabeth M Wever; Anssi Auvinen; Jonas Hugosson; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Arnauld Villers; Alvaro Páez; Sue M Moss; Marco Zappa; Teuvo L J Tammela; Tuukka Mäkinen; Sigrid Carlsson; Ida J Korfage; Marie-Louise Essink-Bot; Suzie J Otto; Gerrit Draisma; Chris H Bangma; Monique J Roobol; Fritz H Schröder; Harry J de Koning
Journal:  N Engl J Med       Date:  2012-08-16       Impact factor: 91.245

7.  Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.

Authors:  Richard M Martin; Jenny L Donovan; Emma L Turner; Chris Metcalfe; Grace J Young; Eleanor I Walsh; J Athene Lane; Sian Noble; Steven E Oliver; Simon Evans; Jonathan A C Sterne; Peter Holding; Yoav Ben-Shlomo; Peter Brindle; Naomi J Williams; Elizabeth M Hill; Siaw Yein Ng; Jessica Toole; Marta K Tazewell; Laura J Hughes; Charlotte F Davies; Joanna C Thorn; Elizabeth Down; George Davey Smith; David E Neal; Freddie C Hamdy
Journal:  JAMA       Date:  2018-03-06       Impact factor: 56.272

8.  Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

Authors:  Hans Lilja; David Ulmert; Thomas Björk; Charlotte Becker; Angel M Serio; Jan-Ake Nilsson; Per-Anders Abrahamsson; Andrew J Vickers; Göran Berglund
Journal:  J Clin Oncol       Date:  2007-02-01       Impact factor: 44.544

9.  Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.

Authors:  Sigrid Carlsson; Melissa Assel; Daniel Sjoberg; David Ulmert; Jonas Hugosson; Hans Lilja; Andrew Vickers
Journal:  BMJ       Date:  2014-03-28

10.  Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

Authors:  Alex Tsodikov; Roman Gulati; Eveline A M Heijnsdijk; Paul F Pinsky; Sue M Moss; Sheng Qiu; Tiago M de Carvalho; Jonas Hugosson; Christine D Berg; Anssi Auvinen; Gerald L Andriole; Monique J Roobol; E David Crawford; Vera Nelen; Maciej Kwiatkowski; Marco Zappa; Marcos Luján; Arnauld Villers; Eric J Feuer; Harry J de Koning; Angela B Mariotto; Ruth Etzioni
Journal:  Ann Intern Med       Date:  2017-09-05       Impact factor: 25.391
View more
  1 in total

Review 1.  Health inequity drives disease biology to create disparities in prostate cancer outcomes.

Authors:  William G Nelson; Otis W Brawley; William B Isaacs; Elizabeth A Platz; Srinivasan Yegnasubramanian; Karen S Sfanos; Tamara L Lotan; Angelo M De Marzo
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.